Dr. Robert Mentz, MD

• Advanced Heart Failure & Transplant Cardiology

• Internal Medicine

• Cardiology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Duke University School Of Medicine

  Fellowship Hospital, 2013

• Brigham And Women's Hospital

  Internship Hospital, 2008

• Emory University

  Medical School, 2007

• Emory University School Of Medicine

  Medical School, 2007

• University Of Richmond

  Undergraduate School, 2003

• Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices, 2016-06-21

• The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF, 2020-03-25

• Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure with Reduced Ejection Fraction: DEFINE-HF, 2022-05-23

• Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events, 2022-11-22

• Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials, 2022-02-08

• Impact of Baseline Covariate Imbalance on Bias in Treatment Effect Estimation in Cluster Randomized Trials: Race as an Example, 2019-06-20

• Polypharmacy in Palliative Care for Advanced Heart Failure: The PAL-HF Experience, 2021-10-07

• Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients with Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial), 2014-06-24

• Impact of Age on Comorbidities and Outcomes in Heart Failure with Reduced Ejection Fraction, 2019-12-06

• International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial, 2014-04-25

• Regional adiposity and heart failure with preserved ejection fraction, 2020-08-05

• Rehabilitation Intervention in Older Patients with Acute Heart Failure with Preserved versus Reduced Ejection Fraction, 2021-07-07

• Predicting Major Adverse Limb Events in Individuals With Type 2 Diabetes: Insights From the EXSCEL Trial, 2021-03-18

• Timing of Cardiac Resynchronization Therapy Device Implantation in Heart Failure Patients and Its Association with Outcomes, 2018-12-26

• Reassessing the Role of Surrogate Endpoints in Drug Development for Heart Failure, 2018-09-04

• The past, present and future of renin-angiotensin aldosterone system inhibition?, 2012-10-31

• Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes, 2023-09-08

• The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial, 2022-02-28

• Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events, 2014-06-27

• Physical Function, Frailty, Cognition, Depression and Quality-of-Life in Hospitalized Adults =60 Years with Acute Decompensated Heart Failure with Preserved versus Reduced Ejection Fraction: Insights from the REHAB-HF Trial, 2018-11-16

• Clinical Characteristics, Response to Exercise Training and Outcomes in Heart Failure Patients with Chronic Obstructive Pulmonary Disease: Findings from HF-ACTION, 2012-11-28

• Race, exercise training, and outcomes in chronic heart failure: Findings from Heart Failure - A Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION), 2013-07-12

• Can Vaccinations Improve Heart Failure Outcomes? Contemporary Data and Future Directions, 2017-02-01

• Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds, 2016-03-01

• Outpatient Worsening Heart Failure as a Target for Therapy, 2018-03-01

• Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL), 2022-06-27

• Patients phenotypes and cardiovascular risk in type 2 diabetes: the Jackson Heart Study, 2022-06-01

• Response to Exercise Training and Outcomes in Patients with Heart Failure and Diabetes Mellitus: Insights from HF-ACTION, 2015-12-11

• Targeting Natriuretic Peptide Levels in Heart Failure with Therapy: Does "X” Really Mark the Spot?, 2019-11-18

• Paving a Better Path for Patients Dying of Heart Disease, 2018-03-20

• Designing effective drug and device development programs for hospitalized heart failure: A proposal for pretrial registries, 2014-05-24

• AMIODARONE USE IN PATIENTS LISTED FOR HEART TRANSPLANT IS ASSOCIATED WITH INCREASED ONE-YEAR POST-TRANSPLANT MORTALITY, 2016-07-17

• Cigarette smoking and incident heart failure: Insights from the Jackson Heart Study, 2018-04-16

• Relationship between Changing Patient-Reported Outcomes and Subsequent Clinical Events in Patients with Chronic Heart Failure: Insights from HF-ACTION, 2018-08-31

• Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial, 2022-04-04

• Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials, 2020-08-21

• Strategies for supporting intervention fidelity in the Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial, 2017-10-25

• Patient Selection for Advanced Heart Failure Therapy Referral, 2014-08-22

• Increasing the US heart transplant donor pool with donation after circulatory death, 2019-09-30

• Acute cardiovascular hospitalizations and illness severity before and during the COVID -19 pandemic, 2021-03-07

• A Gordian Knot: Disentangling Comorbidities in Heart Failure, 2016-07-04

• Spironolactone metabolite concentrations in decompensated heart failure: Insights from the ATHENA-HF trial., 2020-04-01

• Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial, 2017-09-01

• Splanchnic Nerve Block Mediated Changes in Stressed Blood Volume in Heart Failure, 2021-03-10

• Differences in Health Care Use and Outcomes by the Timing of In-Hospital Worsening Heart Failure, 2015-09-11

• A reappraisal of loop diuretic choice in heart failure patients, 2015-01-06

• Hypertensive diseases in pregnancy and kidney function later in life: The Genetic Epidemiology Network of Arteriopathy (GENOA) study, 2021-09-24

• Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change, 2022-03-29

• Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial, 2021-03-10

• Relation of Serum Magnesium Levels and Postdischarge Outcomes in Patients Hospitalized for Heart Failure (from the EVEREST Trial), 2013-10-04

• Trajectory of Congestion Metrics by Ejection Fraction in Patients with Acute Heart Failure (From the Heart Failure Network), 2017-04-12

• IMPACT OF DONOR BRAIN DEATH DURATION ON OUTCOMES FOLLOWING HEART TRANSPLANTATION: A UNOS REGISTRY ANALYSIS, 2019-04-30

• Spironolactone in Acute Heart Failure Patients with Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial, 2019-02-07

• Dysglycemia and Incident Heart Failure among Blacks: The Jackson Heart Study, 2021-11-19

• Relationship of Physical Function with Quality of Life in Older Patients with Acute Heart Failure, 2021-04-10

• Relation of Dyspnea Severity on Admission for Acute Heart Failure With Outcomes and Costs, 2014-10-15

• Home-Time as a Novel Post-Discharge Outcome for Patients Hospitalized with Heart Failure, 2018-06-12

• The burden of proof: The current state of atrial fibrillation prevention and treatment trials, 2017-02-02

• Multi-national and multi-ethnic variations in health-related quality of life in patients with chronic heart failure, 2017-07-01

• Renal Outcomes in Patients Bridged to Heart Transplant with a Left Ventricular Assist Device, 2020-01-03

• Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow?, 2015-12-15

• Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes - Findings from ASCEND-HF, 2016-10-09

• Cognition, Physical Function and Quality-of-Life in Older Patients with Acute Decompensated Heart Failure, 2020-09-18

• Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) Trial: Design and Rationale, 2016-12-28

• Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score, 2015-12-21

• Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure Patients: Insights from HF-ACTION, 2016-03-15

• Intentional and Unintentional Medication Non-Adherence in African Americans: Insights from the Jackson Heart Study, 2018-03-12

• Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial, 2021-11-01

• Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial, 2019-09-23

• Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions, 2014-08-22

• Representativeness of Medicare Participants in the Jackson Heart Study for African American Medicare Beneficiaries, 2017-05-28

• Obesity Status and Physical Rehabilitation in Older Patients Hospitalized With Acute HF Insights From REHAB-HF, 2022-09-07

• Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction, 2014-11-24

• The Palliative Care in Heart Failure (PAL-HF) Randomized, Controlled Clinical Trial, 2017-07-18

• Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial, 2015-06-17

• Charting a Roadmap for Heart Failure Biomarker Studies, 2014-06-11

• Reassessing Recipient Mortality Under the New Heart Allocation System: An Updated UNOS Registry Analysis, 2020-05-14